EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid–Gambogic Acid Nanocrystals

Xiwen Zeng, Sizhuo Liu, Qianhui He, Yanwen Ling, Jingqi Sun iD, Yang Ping, Jin Su

Pharmaceutics · 18.02.2026 · 18 (2) · 253

DOI: 10.3390/pharmaceutics18020253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 18.02.2026. Verfasst von Xiwen Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Province North Medicine and Functional Food Characteristics Subject, Heilongjiang Provincial Natural Science Foundation of China, The Basic Research Support Program for Excellent Young Teachers in Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver cancer is a complex malignant tumor; gambogic acid (GA) has significant anti-cancer potential, but poor water solubility and low bioavailability limit its clinical application. In this paper, by integrating nanocrystal (NC) technology and an active targeting strategy, a new nanoagent—folic acid-modified phospholipid–gambogic acid nanocrystals (GA-NCs@FA)—was developed to improve the delivery efficiency and therapeutic effect of GA in the treatment of liver cancer.

Methods

GA-NCs@FA was prepared by the CO2-assisted precipitation method and the thin-film hydration method. The in vitro anti-tumor activity of GA-NCs@FA was evaluated by cytotoxicity, as well as a scratch and uptake test. A HepG2 tumor-bearing nude mouse model was established to investigate the in vivo distribution and tumor targeting of GA. The in vivo anti-tumor activity was evaluated by the tumor inhibition rate, and the pathological changes of organs in each group were observed by H&E staining.

Results

GA-NCs@FA significantly reduced HepG2 cell viability (IC50: 0.50 μg·mL−1) and migration ability (48 h healing rate: 11.50%) and enhanced intracellular fluorescence intensity. In vivo analysis showed that GA-NCs@FA significantly increased the accumulation of drugs in tumor tissues by active targeting and achieved a tumor growth inhibition rate of 70.9%. Histopathology confirmed that GA-NCs@FA induced the most obvious nuclear pyknosis and necrosis in tumor tissues while maintaining good biosafety.

Conclusions

GA-NCs@FA significantly prolongs the systemic circulation time of the drug and enhances intratumoral accumulation; therefore, it is a method that can be considered for active targeting and treatment of liver cancer.

Schlagwörter

Stichwörter der Autor:innen

folic acid modificationgambogic acidhepatocellular carcinomananocrystalstumor-targeted therapy

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, China Jiamusi University, Jiamusi 154007, China.
  • Heilongjiang Provincial Key Laboratory of New Drug Development and Pharmacotoxicological Evaluation, Jiamusi University, Jiamusi 154007, China.

ORCID-Profile: Jingqi Sun

Förderung

  • Heilongjiang Province North Medicine and Functional Food Characteristics Subject
  • Heilongjiang Provincial Natural Science Foundation of China
  • The Basic Research Support Program for Excellent Young Teachers in Heilongjiang Province
  • National College Student Innovation and Entrepreneurship Training Program
  • Heilongjiang Provincial Key Laboratory Fund of New Drug Development and Evaluation of Toxicology
  • North Medicine and Functional Food Characteristic Subject Project in Heilongjiang Province
  • Basic Research Support Program for Excellent Young Teachers in Heilongjiang Province

Zitieren

APA

Zeng, X., Liu, S., He, Q., Ling, Y., Sun, J., Ping, Y., & Su, J. (2026). Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid–Gambogic Acid Nanocrystals. Pharmaceutics, 18(2), 253. https://doi.org/10.3390/pharmaceutics18020253

Vancouver

Zeng X, Liu S, He Q, Ling Y, Sun J, Ping Y, et al. Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid–Gambogic Acid Nanocrystals. Pharmaceutics. 2026;18(2):253. doi:10.3390/pharmaceutics18020253

BibTeX
@article{Zeng2026,
  author = {Zeng, Xiwen and Liu, Sizhuo and He, Qianhui and Ling, Yanwen and Sun, Jingqi and Ping, Yang and Su, Jin},
  title = {Preparation and Antitumor Activity Evaluation of Folic Acid-Modified Phospholipid–Gambogic Acid Nanocrystals},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {253},
  doi = {10.3390/pharmaceutics18020253}
}
Kostenlos starten →